Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
SUSPENDED
120 participants
OBSERVATIONAL
2019-12-01
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Infections in Hospitalized Cirrhotic Patients
NCT03137719
Short Term Outcomes in Hospitalized Patients With Liver Cirrhosis
NCT05848414
Prospective Cohort Study of Disease and Outcomes in Cirrhosis
NCT04422223
Validation of New Prognostic Biomarkers in Patients With Decompensated Cirrhosis
NCT06855056
Effect of Liver Injury on Mortality in Coronavirus Disease-2019 Patients Admitted to Intensive Care Unit
NCT04669509
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Liver cirrhosis with spironolactone
There is no intervention, only research blood samples are collected
Research blood samples collected
Liver cirrhosis with rifaximin
There is no intervention, only research blood samples are collected
Research blood samples collected
Liver cirrhosis without spironolactone or rifaximin
There is no intervention, only research blood samples are collected
Research blood samples collected
Pneumonia
There is no intervention, only research blood samples are collected
Research blood samples collected
Crohn's disease
There is no intervention, only research blood samples are collected
Research blood samples collected
Ulcerative colitis
There is no intervention, only research blood samples are collected
Research blood samples collected
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
There is no intervention, only research blood samples are collected
Research blood samples collected
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Treated in the ward 42 of the Oulu University Hospital
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Oulu
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Janne Hukkanen
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Janne Hukkanen, MD
Role: PRINCIPAL_INVESTIGATOR
Oulu University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Oulu University Hospital
Oulu, , Finland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
4bHC kirroosissa
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.